Will the world’s first malaria vaccine eradicate the disease?
WHO approves the first jab against malaria for widespread use among children in Africa.
With the world focused on COVID-19 vaccines, a breakthrough has been made in the fight against another disease.
The World Health Organization (WHO) has approved a malaria vaccine for widespread use among children in Africa.
Recommended Stories
list of 3 items- list 1 of 3Malaria vaccine a ‘breakthrough for science’, WHO chief says
- list 2 of 3WHO to trial malaria, arthritis drugs as COVID treatments
- list 3 of 3Researchers hail possible malaria vaccine breakthrough
It follows decades of development and successful trials in Ghana, Kenya and Malawi.
The WHO and drugmaker GlaxoSmithKline say it is a breakthrough.
Could it help eradicate the disease? And will it be affordable for those who need it most?
Presenter: Kamahl Santamaria
Guests:
Akpaka Kalu – WHO regional adviser for tropical and vector-borne diseases
Helen Rees – Board member, Gavi, the Vaccine Alliance
Abdhalah Ziraba – Research scientist, African Population and Health Research Center
